Non-Current Liabilities

Total Liabilities

Boston Scientific Total Liabilities decreased by 6.8% to $1.58B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026May 1, 2026

How to read this metric

A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.

Detailed definition

This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...

Peer comparison

Used across all industries to assess the overall debt burden relative to equity and assets.

Metric ID: total_liabilities

Historical Data

2 periods
 Q4 '25Q1 '26
Value$1.70B$1.58B
QoQ Change—-6.8%
Range$1.58B – $1.70B

Total Liabilities at Other Companies

Abbott logo
AbbottABTView metric
Johnson & Johnson logo
Johnson & JohnsonJNJView metric
Stryker logo
StrykerSYKView metric
Edwards Lifesciences logo
Edwards LifesciencesEWView metric
Medtronic logo
MedtronicMDTView metric
STERIS logo
STERISSTEView metric

Frequently Asked Questions

What is Boston Scientific's total liabilities?
Boston Scientific (BSX) reported total liabilities of $1.58B in Q1 2026.
What does total liabilities mean?
The total amount of money the company owes to all creditors and stakeholders.